SOPHiA GENETICS (SOPH) Change in Cash (2020 - 2026)

SOPHiA GENETICS has disclosed Change in Cash across 7 years of filings, most recently posting $43.8 million for Q2 2026.

• In Q2 2026, Change in Cash rose 84.38% year-over-year to $43.8 million; the TTM figure through Jun 2026 stood at $13.8 million (up 202.81% YoY), while the FY2025 annual figure was -$14.4 million, up 63.5% from the prior year.
• Change in Cash came in at $43.8 million for Q2 2026 at SOPHiA GENETICS, up from -$4.7 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $43.8 million in Q2 2026 to a low of -$20.5 million in Q3 2022.
• Average Change in Cash over 5 years is -$4.9 million, with a median of -$11.7 million recorded in 2024.
• Year-over-year, Change in Cash tumbled 1242.96% in 2023 and surged 1610.29% in 2025.
• Over 5 years, Change in Cash stood at $1.2 million in 2022, then plunged by 1242.96% to -$14.0 million in 2023, then gained by 6.64% to -$13.1 million in 2024, then gained by 8.31% to -$12.0 million in 2025, then jumped by 464.54% to $43.8 million in 2026.
• Per Business Quant data, the three most recent Change in Cash figures were $43.8 million in Q2 2026, -$4.7 million in Q1 2026, and -$12.0 million in Q4 2025.